Your browser doesn't support javascript.
loading
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
Castellsagué, Xavier; Paavonen, Jorma; Jaisamrarn, Unnop; Wheeler, Cosette M; Skinner, S Rachel; Lehtinen, Matti; Naud, Paulo; Chow, Song-Nan; Del Rosario-Raymundo, Maria Rowena; Teixeira, Julio C; Palmroth, Johanna; de Carvalho, Newton S; Germar, Maria Julieta V; Peters, Klaus; Garland, Suzanne M; Szarewski, Anne; Poppe, Willy A J; Romanowski, Barbara; Schwarz, Tino F; Tjalma, Wiebren A A; Bosch, F Xavier; Bozonnat, Marie-Cecile; Struyf, Frank; Dubin, Gary; Rosillon, Dominique; Baril, Laurence.
Afiliación
  • Castellsagué X; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. xcastellsague@iconcologia.net.
  • Paavonen J; Department of Obstetrics and Gynaecology, University of Helsinki, Helsinki, Finland. Jorma.Paavonen@hus.fi.
  • Jaisamrarn U; Department of Obstetrics and Gynaecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. dr.unnop@yahoo.com.
  • Wheeler CM; Departments of Pathology and Obstetrics and Gynecology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA. CWheeler@salud.unm.edu.
  • Skinner SR; Vaccines Trials Group, Telethon Institute for Child Health Research, Perth, WA and Sydney University Discipline of Paediatrics and Child Health, Children's Hospital Westmead, Sydney, NSW, Australia. rachels5@chw.edu.au.
  • Lehtinen M; University of Tampere, School of Public Health, Tampere, Finland. matti.lehtinen@uta.fi.
  • Naud P; Hospital de Clínicas de Porto Alegre, Department of Gynecology & Obstetrics Federal University of Rio Grande do Sul - UFRGS/HCPA, Porto Alegre, Brazil. cacontrol@hcpa.ufrgs.br.
  • Chow SN; Department of Obstetrics and Gynecology, College of Medicine and the Hospital, National Taiwan University, Taipei, Taiwan. snchow@ntu.edu.tw.
  • Del Rosario-Raymundo MR; San Pablo Colleges Medical Center, San Pablo City, Laguna, Philippines. runnymeadow@yahoo.com.
  • Teixeira JC; Departamento de Tocoginecologia da Unicamp, University of Campinas, Campinas, Sao Paulo, Brazil. juliotex@uol.com.br.
  • Palmroth J; Central Hospital of North Carelian, Department of Obstetrics and Gynecology, Joensuu, Finland. johanna.palmroth@dnainternet.net.
  • de Carvalho NS; Department of Gynecology and Obstetrics, Federal University of Paraná, Infectious Diseases in Gynecology and Obstetrics Sector, Curitiba, Parana, Brazil. infectogin@ufpr.br.
  • Germar MJ; Department of Obstetrics and Gynaecology, University of the Philippines College of Medicine, Philippines General Hospital, Manila, Philippines. jvgermar@yahoo.com.
  • Peters K; Facharzt für Frauenheilkunde und Geburtshilfe, Hamburg, Germany. klaus@dr-peters.net.
  • Garland SM; Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Parkville/Department of Microbiology, The Royal Children's Hospital, Parkville/Murdoch Children's Research Institute, Parkville/Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Victoria, Aust
  • Szarewski A; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Poppe WA; Department of Gynaecology, University Hospital KU Leuven Gasthuisberg, Leuven, Belgium. willy.Poppe@uz.kuleuven.ac.be.
  • Romanowski B; Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. broman@docromanowski.com.
  • Schwarz TF; Central Laboratory and Vaccination Centre, Stiftung Juliusspital, Academic Teaching Hospital of the University of Wuerzburg, Wuerzburg, Germany. t.schwarz@juliusspital.de.
  • Tjalma WA; Multidisciplinary Breast Clinic and Gynaecological Oncology, Antwerp University Hospital, University of Antwerp, Antwerpen, Belgium. wiebren.tjalma@uza.be.
  • Bosch FX; Unit of Infections and Cancer, Cancer Epidemiology Research Program, Institut Català d'Oncologia (ICO), IDIBELL, CIBER-ESP, L'Hospitalet de Llobregat, Avda. Gran via 199-203, 08908 L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain. x.bosch@iconcologia.net.
  • Bozonnat MC; Network on Cooperative Cancer Research, RTICC, Catalonia, Spain. x.bosch@iconcologia.net.
  • Struyf F; 4Clinics, Paris, France. mcbozonnat@4clinics.com.
  • Dubin G; GlaxoSmithKline Vaccines, Wavre, Belgium. FRANK.STRUYF@GSK.COM.
  • Rosillon D; GlaxoSmithKline Vaccines, King of Prussia, PA, USA. Gary.O.Dubin@gsk.com.
  • Baril L; GlaxoSmithKline Vaccines, Wavre, Belgium. DOMINIQUE.X.ROSILLON@GSK.COM.
BMC Infect Dis ; 14: 551, 2014 Oct 30.
Article en En | MEDLINE | ID: mdl-25927224

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Conducta Sexual / Ensayos Clínicos Controlados Aleatorios como Asunto / Displasia del Cuello del Útero / Neoplasias del Cuello Uterino / Infecciones por Papillomavirus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged80 / Female / Humans País/Región como asunto: Europa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2014 Tipo del documento: Article País de afiliación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Conducta Sexual / Ensayos Clínicos Controlados Aleatorios como Asunto / Displasia del Cuello del Útero / Neoplasias del Cuello Uterino / Infecciones por Papillomavirus Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged80 / Female / Humans País/Región como asunto: Europa Idioma: En Revista: BMC Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2014 Tipo del documento: Article País de afiliación: España